Synergism between GGTIand docetaxel was observed across a broad range of concentrations.In conclusion, our results demonstrated that GGTI can inhibit thegrowth of prostate cancer cells and has synergistic effect withdocetaxel, suggesting its potential role in prostate cancertreatment. The gene discussed is PGGT1B; the disease is prostate carcinoma.